MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$22,826K
Net Income
-$6,200K
Net Profit Margin
-27.16%
EPS
-$0.18
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
22,826
22,068
26,588
27,354
Cost of goods sold
3,920
4,020
6,010
6,186
Gross profit
18,906
18,048
20,578
21,168
Sales and marketing
12,124
11,583
10,936
12,598
Research and development
6,898
7,189
7,027
6,576
General and administrative
5,027
4,844
4,382
4,594
Total operating expenses
24,049
23,616
22,345
23,768
Loss from continuing operations
-5,143
-5,568
-1,767
-2,600
Interest income
523
565
638
667
Interest expense
1,539
1,521
1,600
1,645
Other income (expense), net
-41
-165
0
82
Net loss and comprehensive loss from continuing operations
-6,200
-
-
-
Net income from discontinued operations
0
-
-
-
Net loss and comprehensive loss
-6,200
-6,689
-2,729
-3,496
Basic EPS
-0.18
-0.2
-0.082
-0.11
Diluted EPS
-0.18
-0.2
-0.082
-0.11
Basic Average Shares
34,104,430
33,716,813
33,411,204
33,134,606
Diluted Average Shares
34,104,430
33,716,813
33,411,204
33,134,606
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss and
comprehensive loss
-$6,200K
(28.33%↑ Y/Y)
Net loss and
comprehensive loss from...
-$6,200K
Interest income
$523K
(-27.16%↓ Y/Y)
Revenue
$22,826K
(-2.95%↓ Y/Y)
Loss from continuing
operations
-$5,143K
(24.63%↑ Y/Y)
Interest expense
$1,539K
(-25.25%↓ Y/Y)
Gross profit
$18,906K
(4.27%↑ Y/Y)
Other income
(expense), net
-$41K
(91.56%↑ Y/Y)
Cost of goods sold
$3,920K
(-27.25%↓ Y/Y)
Total operating
expenses
$24,049K
(-3.63%↓ Y/Y)
Sales and marketing
$12,124K
(0.67%↑ Y/Y)
Research and development
$6,898K
(0.77%↑ Y/Y)
General and
administrative
$5,027K
(-17.16%↓ Y/Y)
Buy us a coffee
NeuroPace Inc (NPCE)
NeuroPace Inc (NPCE)